JWH-176
 | |
| Systematic (IUPAC) name | |
|---|---|
|
1-([(1E)-3-pentylinden-1-ylidine]methyl)naphthalene | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
619294-62-1  |
| ChemSpider | 29341653 |
| Chemical data | |
| Formula | C25H24 |
| Molar mass | 324.457 g/mol |
| |
| |
| (verify) | |
JWH-176 is an analgesic drug which acts as a cannabinoid receptor agonist. Its binding affinity at the CB1 receptor is only 26.0nM, making it more potent than THC itself,[1] however JWH-176 is particularly notable in that it is a hydrocarbon containing no heteroatoms. This demonstrates that reasonably high-affinity cannabinoid binding and agonist effects can be produced by compounds with no hydrogen bonding capacity at all, relying merely on Van der Waals interactions to bind to the receptor.[2] It was discovered by, and named after, Dr. John W. Huffman.
See also
References
- ↑ Huffman JW, Padgett LW. Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes. Current Medicinal Chemistry, 2005; 12: 1395-1411.
- ↑ Roger Pertwee. Cannabinoids. Handbook of Experimental Pharmacology Volume 168, p 269. Springer. ISBN 3-540-22565-X
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.